PEGCETACOPLAN

PEGCETACOPLAN was reported 1899 times

PEGCETACOPLAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CSF SHUNT CONVERSION 1 1.0000
1 ANTERIOR SEGMENT NEOVASCULARISATION 8 0.6667
2 INJECTION SITE FOREIGN BODY SENSATION IN EYE 2 0.5000
3 COMPLEMENT SPLIT PRODUCTS INCREASED 2 0.5000
4 FLUORESCENCE ANGIOGRAM ABNORMAL 5 0.4545
5 AQUEOUS MISDIRECTION 1 0.3333
6 BODY FLUID ANALYSIS 1 0.2500
7 BREAKTHROUGH HAEMOLYSIS 96 0.2406
8 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 16 0.2192
9 ORAL PURPURA 2 0.1818
10 BULLOUS KERATOPATHY 2 0.1429
11 RETINAL OCCLUSIVE VASCULITIS 31 0.1384
12 NONINFECTIVE CHORIORETINITIS 4 0.1333
13 IMMUNE-COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 3 0.1154
14 INTRA-OCULAR INJECTION COMPLICATION 25 0.1101
15 EYE COMPLICATION ASSOCIATED WITH DEVICE 29 0.1078
16 ANTERIOR SEGMENT ISCHAEMIA 2 0.1053
17 PSEUDOPHAKIA 8 0.0920
18 MACULAR OPACITY 2 0.0909
19 CILIARY ZONULAR DEHISCENCE 1 0.0909
20 IRIS NEOVASCULARISATION 10 0.0800
21 IRIS HAEMORRHAGE 4 0.0784
22 OPTIC DISC OEDEMA 9 0.0776
23 CHOROIDAL NEOVASCULARISATION 65 0.0758
24 VITREAL CELLS 15 0.0743
25 ANTERIOR CHAMBER OPACITY 1 0.0714
26 CHRONIC TRAUMATIC ENCEPHALOPATHY 1 0.0714
27 VITREOUS FIBRIN 2 0.0714
28 SPLENIC EMBOLISM 8 0.0696
29 INFUSION SITE CYST 2 0.0625
30 HAEMANGIOMA RUPTURE 1 0.0625
31 ANTI-HLA ANTIBODY TEST POSITIVE 1 0.0588
32 EYE NAEVUS 6 0.0526
33 ANTERIOR CHAMBER PIGMENTATION 1 0.0500
34 BACTERIAL ENDOPHTHALMITIS 13 0.0489
35 HYALOSIS ASTEROID 2 0.0488
36 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 66 0.0472
37 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 22 0.0469
38 RETINAL VASCULITIS 52 0.0437
39 C3 GLOMERULOPATHY 9 0.0435
40 VITRITIS 75 0.0405
41 DISSEMINATED GONOCOCCAL INFECTION 1 0.0370
42 ANTERIOR CHAMBER CELL 24 0.0336
43 VITREOUS HAZE 5 0.0327
44 EPIRETINAL MEMBRANE 9 0.0324
45 ARCUS LIPOIDES 2 0.0317
46 CENTRAL VISION LOSS 7 0.0314
47 EXTRAVASCULAR HAEMOLYSIS 13 0.0306
48 VITREOUS DEGENERATION 5 0.0305
49 NAIL DEFORMATION 2 0.0299
50 COMPLEMENT FACTOR C3 INCREASED 3 0.0286
51 RETINAL FIBROSIS 2 0.0278
52 KERATORHEXIS 3 0.0263
53 DRY AGE-RELATED MACULAR DEGENERATION 27 0.0243
54 MACULAR THICKENING 2 0.0238
55 OCULAR ISCHAEMIC SYNDROME 2 0.0235
56 ABSCESS SWEAT GLAND 1 0.0222
57 MEGAKARYOCYTES DECREASED 2 0.0215
58 OCULAR PROCEDURAL COMPLICATION 4 0.0206
59 BIOPSY KIDNEY ABNORMAL 4 0.0205
60 GIANT PAPILLARY CONJUNCTIVITIS 1 0.0200
61 LYMPH NODE ABSCESS 2 0.0196
62 HYPHAEMA 10 0.0192
63 VITREOUS OPACITIES 16 0.0189
64 ANTERIOR CHAMBER INFLAMMATION 11 0.0185
65 RETINAL ISCHAEMIA 11 0.0180
66 EXUDATIVE RETINOPATHY 1 0.0175
67 OPTIC NERVE INFARCTION 2 0.0169
68 ADMINISTRATION SITE NODULE 1 0.0167
69 BORDERLINE GLAUCOMA 3 0.0162
70 VITREOUS DETACHMENT 32 0.0148
71 EYE EXCISION 3 0.0146
72 RHEGMATOGENOUS RETINAL DETACHMENT 3 0.0144
73 HYPOTONY OF EYE 6 0.0143
74 HAEMOLYSIS 109 0.0141
75 CATARACT CORTICAL 2 0.0134
76 CHOROIDITIS 5 0.0134
77 ANTERIOR CHAMBER FLARE 3 0.0129
78 BACTERIAL TRANSLOCATION 4 0.0126
79 BLOOD LACTATE DEHYDROGENASE 1 0.0123
80 RETINAL INFARCTION 3 0.0122
81 CHORIORETINAL SCAR 1 0.0120
82 COMPLEMENT FACTOR INCREASED 1 0.0119
83 VITREOUS FLOATERS 116 0.0118
84 POSTERIOR CAPSULE OPACIFICATION 4 0.0117
85 IRITIS 35 0.0115
86 RETICULOCYTE COUNT INCREASED 9 0.0111
87 ADMINISTRATION SITE INFLAMMATION 1 0.0111
88 HAPTOGLOBIN ABNORMAL 1 0.0109
89 EYE OPACITY 1 0.0109
90 OCULAR HYPERTENSION 21 0.0108
91 MENINGOCOCCAL SEPSIS 2 0.0105
92 INJECTION SITE ECZEMA 2 0.0104
93 EYE INFECTION STAPHYLOCOCCAL 3 0.0104
94 BLOOD LACTATE DEHYDROGENASE ABNORMAL 7 0.0103
95 RETINAL VASCULAR DISORDER 6 0.0103
96 CORNEAL OEDEMA 23 0.0103
97 CHORIORETINAL DISORDER 2 0.0102
98 ASPLENIA 1 0.0101
99 EYE INFARCTION 1 0.0100
100 IRIDOCYCLITIS 31 0.0098
101 VISUAL ACUITY REDUCED TRANSIENTLY 3 0.0097
102 CAMPYLOBACTER INFECTION 8 0.0096
103 CHORIORETINITIS 6 0.0093
104 ACID BASE BALANCE ABNORMAL 2 0.0089
105 INTRAVASCULAR HAEMOLYSIS 5 0.0089
106 RETINAL ARTERY THROMBOSIS 2 0.0088
107 CHOLURIA 3 0.0088
108 CONJUNCTIVAL OEDEMA 9 0.0088
109 OPTIC DISC HAEMORRHAGE 2 0.0087
110 ANTERIOR CHAMBER DISORDER 2 0.0087
111 RENAL CORTICAL NECROSIS 2 0.0086
112 RETINAL HAEMORRHAGE 61 0.0086
113 HYPOPYON 7 0.0085
114 KERATIC PRECIPITATES 4 0.0084
115 CHARLES BONNET SYNDROME 1 0.0083
116 COMPLICATIONS OF BONE MARROW TRANSPLANT 3 0.0083
117 NON-INFECTIOUS ENDOPHTHALMITIS 7 0.0082
118 HAEMOGLOBINURIA 9 0.0080
119 RETINAL NEOVASCULARISATION 2 0.0079
120 CIRCUMORAL SWELLING 1 0.0078
121 HAEMORRHAGIC VASCULITIS 1 0.0076
122 KLEBSIELLA URINARY TRACT INFECTION 2 0.0075
123 EYE INFLAMMATION 72 0.0075
124 CATARACT NUCLEAR 5 0.0075
125 ASYMPTOMATIC BACTERIURIA 1 0.0074
126 HAPTOGLOBIN INCREASED 1 0.0073
127 SUDDEN VISUAL LOSS 2 0.0072
128 ENDOPHTHALMITIS 43 0.0072
129 BLOOD CORTICOTROPHIN INCREASED 2 0.0069
130 INFUSION SITE DISCOLOURATION 6 0.0068
131 DERMATOCHALASIS 1 0.0068
132 ENDOCARDITIS NONINFECTIVE 1 0.0067
133 RETINOPATHY HYPERTENSIVE 2 0.0066
134 RETINAL DEPIGMENTATION 2 0.0065
135 ABDOMINAL WALL WOUND 1 0.0065
136 INJECTION SITE PALLOR 2 0.0063
137 GLOMERULOSCLEROSIS 4 0.0063
138 HAPTOGLOBIN DECREASED 5 0.0062
139 DECREASED GAIT VELOCITY 1 0.0060
140 UVEITIS 80 0.0059
141 ACUTE CARDIAC EVENT 1 0.0058
142 VITREOUS HAEMORRHAGE 16 0.0058
143 PTERYGIUM 2 0.0058
144 ARTERIOVENOUS FISTULA OCCLUSION 1 0.0057
145 SUBRETINAL FLUID 6 0.0055
146 APPLICATION SITE HAEMATOMA 1 0.0055
147 ADMINISTRATION SITE DISCOMFORT 1 0.0053
148 APPLICATION SITE INJURY 1 0.0053
149 CHOROIDAL HAEMORRHAGE 1 0.0052
150 EXPOSURE TO EXTREME TEMPERATURE 1 0.0052
151 GENITAL INFECTION FEMALE 1 0.0052
152 URINARY CASTS 2 0.0051
153 METAMORPHOPSIA 9 0.0049
154 DYSCHROMATOPSIA 4 0.0048
155 BLOOD PRODUCT TRANSFUSION DEPENDENT 2 0.0048
156 OPTICAL COHERENCE TOMOGRAPHY ABNORMAL 4 0.0047
157 RETICULOCYTE COUNT DECREASED 2 0.0046
158 SYSTOLIC HYPERTENSION 2 0.0046
159 INFUSION SITE MASS 5 0.0046
160 INFUSION SITE SCAR 2 0.0045
161 DRUG LEVEL FLUCTUATING 4 0.0045
162 OPTIC ISCHAEMIC NEUROPATHY 17 0.0044
163 INTRAOCULAR PRESSURE INCREASED 56 0.0044
164 CORNEAL ABRASION 6 0.0044
165 RETINAL EXUDATES 4 0.0043
166 PRIMARY BILIARY CHOLANGITIS 2 0.0043
167 INFUSION SITE HAEMATOMA 2 0.0042
168 INFUSION SITE BRUISING 9 0.0042
169 CORNEAL DEGENERATION 1 0.0041
170 EVANS SYNDROME 2 0.0041
171 GENE MUTATION 8 0.0040
172 BUDD-CHIARI SYNDROME 1 0.0040
173 IRIS ADHESIONS 2 0.0039
174 LABORATORY TEST INTERFERENCE 3 0.0038
175 CONJUNCTIVITIS VIRAL 1 0.0038
176 CONJUNCTIVAL HAEMORRHAGE 14 0.0037
177 PRESBYOPIA 2 0.0036
178 PRODUCT CLOSURE ISSUE 2 0.0036
179 BILE ACID MALABSORPTION 1 0.0035
180 INFUSION SITE PRURITUS 11 0.0035
181 RETINAL VEIN OCCLUSION 10 0.0035
182 HAEMATOMA INFECTION 2 0.0035
183 ABDOMINAL WALL DISORDER 1 0.0034
184 HEPATORENAL FAILURE 2 0.0033
185 ENTEROBACTER BACTERAEMIA 1 0.0033
186 PUNCTATE KERATITIS 3 0.0033
187 OPEN ANGLE GLAUCOMA 2 0.0033
188 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0032
189 FEAR OF EATING 1 0.0032
190 BLADDER INJURY 1 0.0031
191 NECROTISING RETINITIS 2 0.0031
192 ALLERGY TO ARTHROPOD BITE 1 0.0031
193 PHYSICAL DECONDITIONING 8 0.0031
194 RETINAL DEGENERATION 4 0.0031
195 ADMINISTRATION SITE SWELLING 1 0.0031
196 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
197 RESPIRATORY TRACT INFECTION VIRAL 7 0.0030
198 ECTROPION 1 0.0030
199 MARROW HYPERPLASIA 2 0.0029
200 URETHRAL STENOSIS 2 0.0029
201 EPISCLERITIS 2 0.0029
202 ADMINISTRATION SITE BRUISE 1 0.0029
203 APLASTIC ANAEMIA 15 0.0029
204 FOREARM FRACTURE 2 0.0029
205 BLOOD LACTATE DEHYDROGENASE INCREASED 44 0.0028
206 ANAESTHESIA 1 0.0027
207 OESOPHAGEAL SPASM 5 0.0027
208 INFUSION SITE SWELLING 17 0.0027
209 PAPILLOEDEMA 12 0.0027
210 HAEMOGLOBIN ABNORMAL 17 0.0026
211 RETINAL OEDEMA 5 0.0026
212 DEVICE DISPENSING ERROR 3 0.0025
213 RENAL TUBULAR INJURY 3 0.0025
214 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
215 RETINAL TEAR 6 0.0024
216 LEUKOCYTURIA 2 0.0024
217 GIANT CELL ARTERITIS 2 0.0024
218 CORNEAL DYSTROPHY 1 0.0024
219 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
220 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
221 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
222 STAPHYLOCOCCUS TEST POSITIVE 5 0.0024
223 ENDOCRINE OPHTHALMOPATHY 2 0.0023
224 BLINDNESS TRANSIENT 17 0.0023
225 EYELID INFECTION 1 0.0023
226 BLADDER HYPERTROPHY 1 0.0023
227 PRODUCT TEMPERATURE EXCURSION ISSUE 11 0.0021
228 CATHETER SITE SWELLING 2 0.0021
229 RENAL TUBULAR DISORDER 6 0.0021
230 CYSTOID MACULAR OEDEMA 4 0.0021
231 NOROVIRUS INFECTION 3 0.0021
232 BLOOD URINE 2 0.0021
233 RED BLOOD CELLS URINE POSITIVE 2 0.0021
234 BLOOD URIC ACID DECREASED 1 0.0021
235 PHOTOPSIA 13 0.0021
236 HAEMOPHILUS INFECTION 2 0.0020
237 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 1 0.0020
238 SKIN STRIAE 3 0.0020
239 SYSTEMIC CANDIDA 5 0.0020
240 RETINAL ARTERY OCCLUSION 5 0.0020
241 AGE-RELATED MACULAR DEGENERATION 3 0.0020
242 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 1 0.0019
243 CRYPTOSPORIDIOSIS INFECTION 1 0.0019
244 CORNEAL EROSION 1 0.0019
245 FRACTURE PAIN 1 0.0019
246 IRON OVERLOAD 2 0.0019
247 MACULAR OEDEMA 10 0.0018
248 STRESS AT WORK 2 0.0018
249 CORTISOL DECREASED 2 0.0017
250 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
251 ADMINISTRATION SITE PAIN 2 0.0017
252 CORNEAL EPITHELIUM DEFECT 1 0.0017
253 CELLULITIS ORBITAL 1 0.0017
254 GRAFT COMPLICATION 1 0.0017
255 AMBLYOPIA 1 0.0017
256 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
257 CORONARY ARTERY RESTENOSIS 1 0.0017
258 GLOMERULONEPHRITIS 4 0.0016
259 INFUSION SITE PAIN 21 0.0016
260 BLOOD IRON INCREASED 3 0.0016
261 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
262 OCULAR DISCOMFORT 17 0.0015
263 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
264 GENITAL SWELLING 1 0.0014
265 EYE HAEMORRHAGE 19 0.0014
266 CHROMATURIA 32 0.0014
267 VISUAL FIELD DEFECT 10 0.0014
268 CENTRAL OBESITY 1 0.0014
269 BLINDNESS 55 0.0013
270 INJECTION SITE PARAESTHESIA 2 0.0013
271 HYPERTROPHIC CARDIOMYOPATHY 2 0.0013
272 CRITICAL ILLNESS 1 0.0013
273 EYELID FUNCTION DISORDER 1 0.0013
274 HAEMOGLOBIN DECREASED 129 0.0013
275 HEAT EXHAUSTION 1 0.0012
276 OPTIC ATROPHY 2 0.0012
277 DEVICE INFUSION ISSUE 3 0.0012
278 CSF PROTEIN INCREASED 1 0.0012
279 GASTRIC DILATATION 2 0.0012
280 PRODUCT CONTAMINATION PHYSICAL 3 0.0012
281 VISUAL IMPAIRMENT 145 0.0012
282 MILIARIA 2 0.0012
283 RETINITIS 2 0.0012
284 BLOOD CREATININE ABNORMAL 4 0.0012
285 CATHETER SITE PAIN 3 0.0012
286 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
287 INFUSION SITE DISCHARGE 2 0.0011
288 FOLLICULAR LYMPHOMA 1 0.0011
289 HAEMORRHAGE SUBCUTANEOUS 4 0.0011
290 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 1 0.0011
291 CONJUNCTIVAL HYPERAEMIA 4 0.0011
292 ABDOMINAL NEOPLASM 1 0.0011
293 SWELLING OF EYELID 7 0.0011
294 OPHTHALMIC HERPES ZOSTER 2 0.0011
295 UTERINE LEIOMYOMA 8 0.0011
296 ESCHERICHIA INFECTION 9 0.0011
297 COLOUR BLINDNESS 1 0.0011
298 PNEUMONIA KLEBSIELLA 2 0.0011
299 HAEMOCHROMATOSIS 1 0.0011
300 INJECTION SITE INDURATION 14 0.0011
301 LUPUS NEPHRITIS 2 0.0011
302 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
303 INJECTION SITE SCAR 3 0.0011
304 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
305 VISUAL ACUITY REDUCED 34 0.0010
306 HYPOGEUSIA 2 0.0010
307 JOINT NOISE 2 0.0010
308 PHOTOPHOBIA 19 0.0010
309 INFUSION SITE REACTION 3 0.0010
310 BONE MARROW DISORDER 3 0.0010
311 MYELOFIBROSIS 3 0.0010
312 EYE INJURY 3 0.0010
313 RENAL HAEMORRHAGE 2 0.0010
314 EXTRAVASATION 4 0.0010
315 CAROTID ARTERIOSCLEROSIS 1 0.0010
316 CAPILLARY LEAK SYNDROME 2 0.0010
317 OPTIC NEUROPATHY 2 0.0009
318 POLYMYALGIA RHEUMATICA 3 0.0009
319 TENSION HEADACHE 4 0.0009
320 ACARODERMATITIS 1 0.0009
321 INFUSION SITE HAEMORRHAGE 3 0.0009
322 CLOSTRIDIUM TEST POSITIVE 2 0.0009
323 EYE PAIN 51 0.0009
324 MYELODYSPLASTIC SYNDROME 13 0.0009
325 CYTOPENIA 11 0.0009
326 PRODUCT LEAKAGE 5 0.0009
327 CATHETER SITE DISCHARGE 1 0.0009
328 EYE INFECTION 10 0.0009
329 HALO VISION 1 0.0009
330 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
331 RETINAL DETACHMENT 8 0.0009
332 INJECTION SITE DISCOMFORT 9 0.0009
333 DISCOURAGEMENT 2 0.0009
334 DYSPLASIA 1 0.0008
335 INCORRECT PRODUCT ADMINISTRATION DURATION 18 0.0008
336 INFUSION SITE ERYTHEMA 7 0.0008
337 BRAIN FOG 13 0.0008
338 EYE OEDEMA 2 0.0008
339 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
340 BLOOD URINE PRESENT 15 0.0008
341 BONE MARROW FAILURE 16 0.0008
342 GLUCOSE URINE PRESENT 1 0.0008
343 FOREIGN BODY SENSATION IN EYES 5 0.0008
344 BLOOD BILIRUBIN ABNORMAL 1 0.0008
345 ENTERITIS 5 0.0008
346 EAR DISCOMFORT 8 0.0008
347 OROPHARYNGEAL DISCOMFORT 7 0.0008
348 BACTERAEMIA 9 0.0008
349 FLANK PAIN 7 0.0007
350 ERYTHEMA OF EYELID 4 0.0007
351 MIGRAINE WITH AURA 2 0.0007
352 CARBON DIOXIDE INCREASED 1 0.0007
353 CORNEAL OPACITY 1 0.0007
354 CALCULUS BLADDER 1 0.0007
355 CLUSTER HEADACHE 1 0.0007
356 SUBDURAL HAEMORRHAGE 2 0.0007
357 DRUG SPECIFIC ANTIBODY 1 0.0007
358 ABSCESS ORAL 1 0.0007
359 APPLICATION SITE INFLAMMATION 1 0.0007
360 DISCHARGE 1 0.0007
361 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
362 UTERINE HAEMORRHAGE 3 0.0007
363 OCULAR HYPERAEMIA 33 0.0007
364 HORDEOLUM 3 0.0007
365 GENERALISED ANXIETY DISORDER 1 0.0007
366 GLAUCOMA 13 0.0007
367 MACULAR DEGENERATION 8 0.0007
368 GASTROINTESTINAL WALL THICKENING 1 0.0007
369 HEAVY MENSTRUAL BLEEDING 6 0.0007
370 VARICES OESOPHAGEAL 2 0.0007
371 OPTIC NEURITIS 6 0.0007
372 PROSTATITIS 2 0.0007
373 BLINDNESS UNILATERAL 9 0.0006
374 SUBCUTANEOUS ABSCESS 3 0.0006
375 AORTIC VALVE DISEASE 1 0.0006
376 ACUTE LEUKAEMIA 1 0.0006
377 IMPAIRED DRIVING ABILITY 7 0.0006
378 THROMBOTIC MICROANGIOPATHY 6 0.0006
379 OTITIS MEDIA 2 0.0006
380 INTENTIONAL DOSE OMISSION 17 0.0006
381 FOOD AVERSION 1 0.0006
382 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
383 BLOOD CHLORIDE INCREASED 1 0.0006
384 FULL BLOOD COUNT ABNORMAL 6 0.0006
385 FIBRIN D DIMER INCREASED 2 0.0006
386 UROSEPSIS 5 0.0005
387 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
388 VIRAL INFECTION 18 0.0005
389 ACUTE PULMONARY OEDEMA 3 0.0005
390 SARS-COV-2 TEST POSITIVE 7 0.0005
391 PROTEINURIA 10 0.0005
392 ARTERIAL DISORDER 1 0.0005
393 DIZZINESS POSTURAL 5 0.0005
394 CONVERSION DISORDER 1 0.0005
395 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
396 PLATELET COUNT DECREASED 54 0.0005
397 BLEPHARITIS 2 0.0005
398 INJECTION SITE SWELLING 38 0.0005
399 EYELID PAIN 1 0.0005
400 VISION BLURRED 67 0.0005
401 APPLICATION SITE EXFOLIATION 2 0.0005
402 PETECHIAE 5 0.0005
403 NASAL DRYNESS 3 0.0005
404 DEVICE CONNECTION ISSUE 1 0.0005
405 FOETAL DISTRESS SYNDROME 1 0.0005
406 CATHETER SITE ERYTHEMA 1 0.0005
407 ABNORMAL SENSATION IN EYE 2 0.0005
408 PYELONEPHRITIS 4 0.0005
409 IMMUNOSUPPRESSION 4 0.0005
410 NEEDLE ISSUE 13 0.0004
411 ADENOCARCINOMA 1 0.0004
412 GASTRIC POLYPS 1 0.0004
413 SCIATICA 7 0.0004
414 HAEMOGLOBIN INCREASED 2 0.0004
415 NEPHROTIC SYNDROME 3 0.0004
416 IMMUNE THROMBOCYTOPENIA 2 0.0004
417 LUMBAR VERTEBRAL FRACTURE 2 0.0004
418 EYELID OEDEMA 5 0.0004
419 YELLOW SKIN 2 0.0004
420 BLOOD TEST ABNORMAL 6 0.0004
421 SPLENOMEGALY 5 0.0004
422 BLOOD IRON DECREASED 5 0.0004
423 EOSINOPHIL COUNT DECREASED 1 0.0004
424 KIDNEY TRANSPLANT REJECTION 2 0.0004
425 RENAL IMPAIRMENT 35 0.0004
426 ENTEROCOCCAL INFECTION 2 0.0004
427 SEPTIC SHOCK 18 0.0004
428 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
429 HAEMATURIA 14 0.0004
430 JAUNDICE 11 0.0004
431 SENSITIVE SKIN 3 0.0004
432 INJECTION SITE EXTRAVASATION 5 0.0004
433 ARTHROPOD BITE 3 0.0004
434 HYPERVOLAEMIA 2 0.0004
435 DRY EYE 20 0.0004
436 CATHETER SITE HAEMORRHAGE 1 0.0004
437 VEIN DISORDER 2 0.0004
438 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
439 ANGLE CLOSURE GLAUCOMA 1 0.0004
440 PRODUCT COLOUR ISSUE 2 0.0004
441 INJECTION SITE PRURITUS 26 0.0004
442 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
443 APHTHOUS ULCER 3 0.0004
444 SERUM FERRITIN INCREASED 2 0.0004
445 BLOOD ALBUMIN DECREASED 3 0.0004
446 ANIMAL BITE 1 0.0004
447 TRANSPLANT REJECTION 3 0.0004
448 ABDOMINAL MASS 1 0.0004
449 HEPATIC CIRRHOSIS 7 0.0004
450 POST PROCEDURAL INFECTION 3 0.0004
451 ABDOMINAL RIGIDITY 1 0.0004
452 NONSPECIFIC REACTION 2 0.0004
453 ASTHENOPIA 2 0.0004
454 GASTRIC ULCER HAEMORRHAGE 2 0.0004
455 STREPTOCOCCAL INFECTION 2 0.0004
456 PERIORBITAL SWELLING 2 0.0004
457 COVID-19 62 0.0004
458 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
459 HAEMATOLOGICAL MALIGNANCY 1 0.0004
460 DERMATITIS CONTACT 4 0.0004
461 EYELID MARGIN CRUSTING 1 0.0003
462 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
463 ADENOVIRUS INFECTION 1 0.0003
464 BILIARY COLIC 1 0.0003
465 VASCULITIS 4 0.0003
466 GASTROINTESTINAL NECROSIS 1 0.0003
467 BLOOD CALCIUM INCREASED 3 0.0003
468 ENERGY INCREASED 2 0.0003
469 LABORATORY TEST ABNORMAL 10 0.0003
470 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
471 BLOOD CULTURE POSITIVE 1 0.0003
472 WRIST FRACTURE 4 0.0003
473 STAPHYLOCOCCAL INFECTION 11 0.0003
474 PLATELET COUNT ABNORMAL 2 0.0003
475 END STAGE RENAL DISEASE 6 0.0003
476 DYSAESTHESIA 1 0.0003
477 CONJUNCTIVITIS 6 0.0003
478 PHARYNGITIS 4 0.0003
479 INFUSION SITE EXTRAVASATION 2 0.0003
480 ACUTE MYELOID LEUKAEMIA 5 0.0003
481 INJECTION SITE DISCOLOURATION 4 0.0003
482 EOSINOPHILIC PNEUMONIA 1 0.0003
483 BILE DUCT STONE 1 0.0003
484 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
485 BLOOD POTASSIUM INCREASED 5 0.0003
486 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
487 BACTERIAL SEPSIS 1 0.0003
488 PRODUCT PREPARATION ISSUE 2 0.0003
489 WALKING AID USER 2 0.0003
490 OVARIAN CYST 3 0.0003
491 BK VIRUS INFECTION 1 0.0003
492 BLOOD BILIRUBIN INCREASED 8 0.0003
493 EYELID PTOSIS 3 0.0003
494 PALLOR 8 0.0003
495 ABNORMAL LOSS OF WEIGHT 2 0.0003
496 GINGIVAL BLEEDING 4 0.0003
497 EYE MOVEMENT DISORDER 2 0.0003
498 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
499 HYPOMAGNESAEMIA 4 0.0003
500 EAR PRURITUS 1 0.0003
501 EMBOLIC STROKE 1 0.0003
502 COLD SWEAT 5 0.0003
503 INFECTION 41 0.0003
504 HAND FRACTURE 2 0.0003
505 FEAR OF INJECTION 2 0.0003
506 GASTROENTERITIS VIRAL 5 0.0003
507 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
508 DYSSTASIA 8 0.0003
509 CUTANEOUS VASCULITIS 1 0.0003
510 ANAPHYLACTIC SHOCK 7 0.0003
511 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
512 HYPOPHOSPHATAEMIA 2 0.0003
513 INFLUENZA 30 0.0003
514 CARDIAC DYSFUNCTION 1 0.0003
515 HEPATIC STEATOSIS 5 0.0003
516 NEPHROPATHY TOXIC 3 0.0003
517 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
518 CATHETER SITE INFECTION 1 0.0003
519 HEPATOCELLULAR CARCINOMA 2 0.0003
520 HAEMODYNAMIC INSTABILITY 2 0.0003
521 HYPERTHERMIA 2 0.0003
522 POST PROCEDURAL COMPLICATION 5 0.0003
523 BLOOD CREATININE INCREASED 17 0.0003
524 THROMBOCYTOPENIA 29 0.0003
525 CONCUSSION 2 0.0003
526 OEDEMA 14 0.0003
527 CARDIOPULMONARY FAILURE 1 0.0003
528 CERVIX CARCINOMA 1 0.0003
529 PRODUCT DOSE OMISSION ISSUE 75 0.0003
530 ACUTE KIDNEY INJURY 39 0.0003
531 PRODUCT USE COMPLAINT 4 0.0003
532 ABSCESS 4 0.0003
533 AZOTAEMIA 1 0.0003
534 FUNGAL SKIN INFECTION 1 0.0002
535 FRUSTRATION TOLERANCE DECREASED 2 0.0002
536 PRODUCT ADMINISTRATION ERROR 5 0.0002
537 BODY TEMPERATURE INCREASED 5 0.0002
538 SMALL INTESTINAL OBSTRUCTION 3 0.0002
539 ANAPHYLACTOID REACTION 1 0.0002
540 MENSTRUAL DISORDER 2 0.0002
541 INJECTION SITE HAEMORRHAGE 19 0.0002
542 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
543 CARDIAC FAILURE CHRONIC 1 0.0002
544 SCAR 4 0.0002
545 DEAFNESS 6 0.0002
546 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
547 URINE OUTPUT DECREASED 2 0.0002
548 DISEASE PROGRESSION 27 0.0002
549 EYE IRRITATION 13 0.0002
550 JOINT RANGE OF MOTION DECREASED 3 0.0002
551 HEAD INJURY 7 0.0002
552 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
553 PRODUCT AVAILABILITY ISSUE 5 0.0002
554 ABDOMINAL HERNIA 1 0.0002
555 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
556 DISEASE COMPLICATION 1 0.0002
557 CATARACT 13 0.0002
558 PNEUMONIA BACTERIAL 2 0.0002
559 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
560 FATIGUE 169 0.0002
561 IRON DEFICIENCY ANAEMIA 2 0.0002
562 APHONIA 3 0.0002
563 GASTRITIS EROSIVE 1 0.0002
564 SKIN REACTION 3 0.0002
565 LEUKAEMIA 2 0.0002
566 CONDITION AGGRAVATED 64 0.0002
567 RED BLOOD CELL COUNT DECREASED 6 0.0002
568 ANAEMIA 40 0.0002
569 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
570 MENTAL IMPAIRMENT 5 0.0002
571 DYSPHONIA 12 0.0002
572 THERAPY CHANGE 2 0.0002
573 LIGAMENT SPRAIN 2 0.0002
574 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
575 RHINORRHOEA 13 0.0002
576 APPLICATION SITE SWELLING 1 0.0002
577 ERYSIPELAS 1 0.0002
578 LACRIMATION INCREASED 6 0.0002
579 FULL BLOOD COUNT DECREASED 4 0.0002
580 CONTUSION 19 0.0002
581 SEPSIS 22 0.0002
582 DRY THROAT 2 0.0002
583 TOOTH ABSCESS 2 0.0002
584 SLUGGISHNESS 2 0.0002
585 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
586 INJECTION SITE PAIN 60 0.0002
587 ENDOCARDITIS 1 0.0002
588 INJECTION SITE ERYTHEMA 24 0.0002
589 EYE DISCHARGE 2 0.0002
590 TRANSFUSION 2 0.0002
591 PYREXIA 65 0.0002
592 FOOD POISONING 1 0.0002
593 BRUXISM 1 0.0002
594 GINGIVITIS 1 0.0002
595 DECREASED ACTIVITY 2 0.0002
596 DEVICE LEAKAGE 8 0.0002
597 NASOPHARYNGITIS 34 0.0002
598 FAECALOMA 1 0.0002
599 BLOOD GLUCOSE FLUCTUATION 2 0.0002
600 HEART RATE ABNORMAL 1 0.0002
601 BLOOD UREA INCREASED 3 0.0002
602 THERAPY NON-RESPONDER 8 0.0002
603 OFF LABEL USE 155 0.0002
604 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
605 CHOLECYSTITIS ACUTE 1 0.0002
606 MICTURITION URGENCY 2 0.0002
607 INTERNAL HAEMORRHAGE 2 0.0002
608 CARDIAC VALVE DISEASE 1 0.0002
609 EXERCISE TOLERANCE DECREASED 1 0.0002
610 SYRINGE ISSUE 3 0.0002
611 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
612 CEREBRAL HAEMORRHAGE 6 0.0002
613 BLOOD PRESSURE FLUCTUATION 4 0.0002
614 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
615 LEUKOCYTOSIS 3 0.0002
616 TREATMENT NONCOMPLIANCE 9 0.0002
617 DERMATITIS ACNEIFORM 1 0.0002
618 ABDOMINAL PAIN 38 0.0002
619 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
620 INJECTION SITE MASS 6 0.0002
621 EYE SWELLING 6 0.0002
622 MIDDLE INSOMNIA 3 0.0002
623 EPISTAXIS 12 0.0002
624 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
625 CELLULITIS 8 0.0002
626 MUSCULOSKELETAL DISORDER 3 0.0002
627 INJECTION SITE IRRITATION 2 0.0002
628 INCREASED APPETITE 3 0.0002
629 HERPES ZOSTER 9 0.0002
630 ERECTILE DYSFUNCTION 4 0.0002
631 CARDIAC FLUTTER 1 0.0002
632 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
633 BRADYPHRENIA 1 0.0002
634 JOINT STIFFNESS 4 0.0002
635 URINARY TRACT INFECTION 26 0.0002
636 ASPERGILLUS INFECTION 1 0.0002
637 SKIN DISCOLOURATION 7 0.0002
638 IMMUNE SYSTEM DISORDER 2 0.0002
639 BLOOD PRESSURE ABNORMAL 3 0.0002
640 APPETITE DISORDER 1 0.0002
641 HEADACHE 92 0.0001
642 MIGRAINE 14 0.0001
643 BLOOD TESTOSTERONE DECREASED 1 0.0001
644 CHILLS 17 0.0001
645 ENCEPHALITIS 1 0.0001
646 DEVICE USE ERROR 5 0.0001
647 DEFAECATION URGENCY 1 0.0001
648 HALLUCINATION, VISUAL 3 0.0001
649 SEASONAL ALLERGY 2 0.0001
650 BACK PAIN 32 0.0001
651 FAECES SOFT 1 0.0001
652 INFLAMMATION 7 0.0001
653 FEELING DRUNK 1 0.0001
654 ABDOMINAL DISTENSION 14 0.0001
655 SNEEZING 3 0.0001
656 PANCREATITIS ACUTE 3 0.0001
657 PNEUMONIA 43 0.0001
658 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
659 DEVICE ADHESION ISSUE 2 0.0001
660 MALAISE 57 0.0001
661 GYNAECOMASTIA 4 0.0001
662 MUSCULOSKELETAL CHEST PAIN 2 0.0001
663 ANKLE FRACTURE 2 0.0001
664 TENDONITIS 2 0.0001
665 APNOEA 1 0.0001
666 PULMONARY EMBOLISM 12 0.0001
667 PRODUCTIVE COUGH 6 0.0001
668 INJECTION SITE BRUISING 10 0.0001
669 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
670 THROMBOSIS 10 0.0001
671 MUSCLE TIGHTNESS 2 0.0001
672 EXTRA DOSE ADMINISTERED 5 0.0001
673 INJECTION SITE URTICARIA 3 0.0001
674 VENTRICULAR TACHYCARDIA 2 0.0001
675 PHOTOSENSITIVITY REACTION 2 0.0001
676 COAGULOPATHY 2 0.0001
677 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
678 POLLAKIURIA 5 0.0001
679 CARDIO-RESPIRATORY ARREST 5 0.0001
680 EYE PRURITUS 4 0.0001
681 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
682 HEMIPARESIS 2 0.0001
683 FACIAL PARALYSIS 1 0.0001
684 HAEMATOMA 3 0.0001
685 DIPLOPIA 3 0.0001
686 RESPIRATORY TRACT INFECTION 3 0.0001
687 PRURITUS 44 0.0001
688 ASTHENIA 43 0.0001
689 GROIN PAIN 1 0.0001
690 LYMPHOCYTE COUNT DECREASED 2 0.0001
691 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
692 HEAD DISCOMFORT 2 0.0001
693 FACIAL PAIN 1 0.0001
694 DECREASED APPETITE 26 0.0001
695 HAEMOLYTIC ANAEMIA 1 0.0001
696 GASTROINTESTINAL INFECTION 1 0.0001
697 RASH PRURITIC 6 0.0001
698 OSTEOMYELITIS 2 0.0001
699 LIMB INJURY 3 0.0001
700 C-REACTIVE PROTEIN INCREASED 4 0.0001
701 PANIC ATTACK 4 0.0001
702 ANAPHYLACTIC REACTION 6 0.0001
703 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
704 PROCEDURAL PAIN 3 0.0001
705 FEELING COLD 3 0.0001
706 SWELLING FACE 7 0.0001
707 BACTERIAL INFECTION 2 0.0001
708 ILLNESS 11 0.0001
709 FRACTURE 2 0.0001
710 GASTRIC ULCER 2 0.0001
711 INCORRECT DOSE ADMINISTERED 24 0.0001
712 HYPERSOMNIA 3 0.0001
713 DIZZINESS 52 0.0001
714 HERNIA 2 0.0001
715 COUGH 29 0.0001
716 PRESCRIBED OVERDOSE 2 0.0001
717 EAR PAIN 2 0.0001
718 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
719 HAEMORRHOIDS 2 0.0001
720 KIDNEY INFECTION 2 0.0001
721 HAEMATOCRIT DECREASED 2 0.0001
722 UPPER LIMB FRACTURE 2 0.0001
723 RESPIRATORY DISORDER 3 0.0001
724 ADVERSE DRUG REACTION 9 0.0001
725 FEEDING DISORDER 2 0.0001
726 DISCOMFORT 6 0.0001
727 INJECTION SITE RASH 3 0.0001
728 PERIPHERAL SWELLING 15 0.0001
729 PRODUCT PREPARATION ERROR 2 0.0001
730 RIB FRACTURE 2 0.0001
731 HYPERSENSITIVITY 18 0.0001
732 ARTHRALGIA 40 0.0001
733 HAEMORRHAGE 10 0.0001
734 FOLLICULITIS 1 0.0001
735 DIARRHOEA 61 0.0001
736 HYPERTENSION 20 0.0001
737 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
738 HYPOTHYROIDISM 3 0.0001
739 METABOLIC ACIDOSIS 3 0.0001
740 LACTIC ACIDOSIS 3 0.0001
741 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
742 FAECES DISCOLOURED 2 0.0001
743 BIPOLAR DISORDER 1 0.0001
744 CHEST PAIN 17 0.0001
745 BLOOD PRESSURE INCREASED 14 0.0001
746 CHOLELITHIASIS 3 0.0001
747 OSTEONECROSIS 3 0.0001
748 EYE DISORDER 3 0.0001
749 GASTROINTESTINAL PAIN 1 0.0001
750 MELAENA 2 0.0001
751 GAIT INABILITY 3 0.0001
752 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
753 NECK PAIN 5 0.0001
754 PANCYTOPENIA 5 0.0001
755 PULMONARY OEDEMA 4 0.0001
756 DEVICE ISSUE 8 0.0001
757 ARTHRITIS 7 0.0001
758 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
759 ERYTHEMA 18 0.0001
760 ABDOMINAL PAIN UPPER 18 0.0001
761 NEPHROLITHIASIS 4 0.0001
762 GASTRIC HAEMORRHAGE 1 0.0001
763 HYPOKALAEMIA 4 0.0001
764 DELIRIUM 3 0.0001
765 SWELLING 8 0.0001
766 CHOLECYSTITIS 1 0.0001
767 ACCIDENT 1 0.0001
768 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
769 VOMITING 39 0.0001
770 LOCALISED INFECTION 2 0.0001
771 CRYING 3 0.0001
772 THERAPEUTIC RESPONSE DECREASED 5 0.0001
773 HYPERGLYCAEMIA 3 0.0001
774 NEURALGIA 2 0.0001
775 OEDEMA PERIPHERAL 10 0.0001
776 CEREBRAL INFARCTION 2 0.0001
777 CARDIOMEGALY 1 0.0001
778 GENERALISED OEDEMA 1 0.0001
779 CYST 1 0.0001
780 CONFUSIONAL STATE 13 0.0001
781 PRODUCT STORAGE ERROR 7 0.0001
782 DYSPNOEA EXERTIONAL 3 0.0001
783 MUSCULAR WEAKNESS 9 0.0001
784 COLITIS 3 0.0001
785 CARDIOVASCULAR DISORDER 2 0.0001
786 FLUID RETENTION 4 0.0001
787 HEPATIC CYTOLYSIS 1 0.0001
788 DEVICE DEPLOYMENT ISSUE 1 0.0001
789 HYPOPHAGIA 2 0.0001
790 FALL 26 0.0001
791 URTICARIA 13 0.0001
792 SKIN ULCER 2 0.0001
793 PALPITATIONS 9 0.0001
794 DEATH 66 0.0001
795 APPLICATION SITE ERYTHEMA 2 0.0001
796 OROPHARYNGEAL PAIN 7 0.0001
797 ADVERSE REACTION 1 0.0001
798 RENAL FAILURE 10 0.0001
799 DEHYDRATION 10 0.0001
800 ABORTION SPONTANEOUS 3 0.0001
801 MENSTRUATION IRREGULAR 2 0.0001
802 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
803 DISTURBANCE IN ATTENTION 4 0.0001
804 FREQUENT BOWEL MOVEMENTS 2 0.0001
805 DYSPHAGIA 7 0.0001
806 NEUTROPENIA 10 0.0001
807 PNEUMONITIS 2 0.0001
808 HEPATIC ENZYME INCREASED 5 0.0001
809 APPLICATION SITE RASH 1 0.0001
810 INJECTION SITE REACTION 5 0.0001
811 ATRIAL FIBRILLATION 7 0.0001
812 DEMENTIA 2 0.0001
813 ABDOMINAL DISCOMFORT 12 0.0001
814 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
815 OSTEOARTHRITIS 3 0.0001
816 NAUSEA 56 0.0001
817 DIALYSIS 1 0.0001
818 SYNCOPE 7 0.0001
819 CARDIOGENIC SHOCK 1 0.0001
820 MOBILITY DECREASED 5 0.0001
821 SOMNOLENCE 14 0.0001
822 LETHARGY 4 0.0001
823 ACCIDENTAL UNDERDOSE 1 0.0001
824 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
825 DEVICE DISLOCATION 3 0.0001
826 GASTROENTERITIS 1 0.0001
827 UNDERDOSE 5 0.0001
828 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
829 SINUSITIS 7 0.0001
830 ASCITES 2 0.0001
831 ACUTE MYOCARDIAL INFARCTION 2 0.0001
832 LIVER DISORDER 3 0.0001
833 TACHYCARDIA 6 0.0001
834 COLON CANCER 1 0.0001
835 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
836 HAEMORRHAGE INTRACRANIAL 1 0.0001
837 BLOOD POTASSIUM DECREASED 2 0.0001
838 CHRONIC KIDNEY DISEASE 5 0.0001
839 MEMORY IMPAIRMENT 9 0.0001
840 SKIN IRRITATION 3 0.0001
841 FEELING HOT 4 0.0001
842 PAIN 40 0.0001
843 DEVICE RELATED INFECTION 1 0.0001
844 RENAL DISORDER 3 0.0001
845 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
846 ARRHYTHMIA 3 0.0001
847 CYSTITIS 2 0.0001
848 RASH ERYTHEMATOUS 3 0.0001
849 CARDIAC FAILURE 5 0.0001
850 NIGHT SWEATS 2 0.0001
851 RASH 27 0.0001
852 DYSPNOEA 35 0.0001
853 BACK DISORDER 1 0.0001
854 LUNG DISORDER 3 0.0001
855 PAIN IN EXTREMITY 18 0.0001
856 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
857 FACE OEDEMA 1 0.0001
858 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
859 DEVICE USE ISSUE 1 0.0001
860 MUSCULOSKELETAL STIFFNESS 5 0.0001
861 EOSINOPHILIA 1 0.0001
862 HYPERKALAEMIA 2 0.0001
863 HEART RATE DECREASED 2 0.0001
864 DEVICE MALFUNCTION 4 0.0001
865 PANCREATITIS 3 0.0001
866 SLEEP DISORDER 4 0.0001
867 DRUG ERUPTION 1 0.0001
868 ANXIETY 16 0.0001
869 GOUT 1 0.0001
870 DRUG INEFFECTIVE 73 0.0001
871 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
872 RESTLESSNESS 2 0.0001
873 LOSS OF CONSCIOUSNESS 7 0.0001
874 HAEMATOCHEZIA 3 0.0001
875 DYSURIA 2 0.0001
876 HYPOAESTHESIA 8 0.0001
877 HYPONATRAEMIA 3 0.0001
878 FLATULENCE 3 0.0001
879 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
880 CHOLESTASIS 1 0.0001
881 ERUCTATION 1 0.0001
882 CHOKING 1 0.0001
883 NASAL CONGESTION 3 0.0001
884 HEART RATE INCREASED 5 0.0001
885 CYTOKINE RELEASE SYNDROME 1 0.0000
886 PLEURAL EFFUSION 3 0.0000
887 VERTIGO 3 0.0000
888 WEIGHT INCREASED 11 0.0000
889 NEUTROPHIL COUNT DECREASED 2 0.0000
890 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
891 CHEST DISCOMFORT 5 0.0000
892 INFLUENZA LIKE ILLNESS 4 0.0000
893 TREMOR 8 0.0000
894 ROAD TRAFFIC ACCIDENT 2 0.0000
895 DERMATITIS 1 0.0000
896 HYPOACUSIS 2 0.0000
897 INTENTIONAL PRODUCT MISUSE 4 0.0000
898 INFUSION RELATED REACTION 3 0.0000
899 FEBRILE NEUTROPENIA 3 0.0000
900 INSOMNIA 12 0.0000
901 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
902 PARAESTHESIA 7 0.0000
903 HEART RATE IRREGULAR 1 0.0000
904 COGNITIVE DISORDER 2 0.0000
905 BURNING SENSATION 3 0.0000
906 INJURY 3 0.0000
907 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
908 NEUROPATHY PERIPHERAL 4 0.0000
909 THERAPY INTERRUPTED 3 0.0000
910 GAIT DISTURBANCE 8 0.0000
911 INTERSTITIAL LUNG DISEASE 2 0.0000
912 MYALGIA 7 0.0000
913 FIBROMYALGIA 1 0.0000
914 AGITATION 3 0.0000
915 BRONCHITIS 3 0.0000
916 AGGRESSION 2 0.0000
917 HOT FLUSH 3 0.0000
918 ABDOMINAL PAIN LOWER 1 0.0000
919 HAEMATEMESIS 1 0.0000
920 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
921 DRUG RESISTANCE 1 0.0000
922 DEPRESSED MOOD 2 0.0000
923 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
924 EAR INFECTION 1 0.0000
925 DRY SKIN 5 0.0000
926 CARDIAC FAILURE CONGESTIVE 3 0.0000
927 DRY MOUTH 3 0.0000
928 DIVERTICULITIS 1 0.0000
929 WEIGHT DECREASED 10 0.0000
930 ALOPECIA 7 0.0000
931 CEREBROVASCULAR ACCIDENT 6 0.0000
932 ANGINA PECTORIS 1 0.0000
933 PRODUCT SUBSTITUTION ISSUE 2 0.0000
934 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
935 BALANCE DISORDER 3 0.0000
936 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
937 GASTROINTESTINAL DISORDER 3 0.0000
938 FEELING ABNORMAL 8 0.0000
939 APHASIA 1 0.0000
940 CORONARY ARTERY DISEASE 1 0.0000
941 STOMATITIS 2 0.0000
942 ILL-DEFINED DISORDER 2 0.0000
943 CONSTIPATION 7 0.0000
944 BONE DENSITY DECREASED 1 0.0000
945 DRUG INTOLERANCE 3 0.0000
946 DEEP VEIN THROMBOSIS 2 0.0000
947 HYPOTENSION 6 0.0000
948 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
949 HEPATIC FUNCTION ABNORMAL 1 0.0000
950 PRODUCT USE ISSUE 5 0.0000
951 DYSARTHRIA 1 0.0000
952 DEPRESSION 6 0.0000
953 SEIZURE 3 0.0000
954 DISORIENTATION 1 0.0000
955 DRUG INTERACTION 4 0.0000
956 JOINT SWELLING 3 0.0000
957 DEVICE BREAKAGE 1 0.0000
958 DYSKINESIA 1 0.0000
959 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
960 COLITIS ULCERATIVE 1 0.0000
961 PRODUCT QUALITY ISSUE 3 0.0000
962 DISEASE RECURRENCE 1 0.0000
963 COMA 1 0.0000
964 DYSPEPSIA 2 0.0000
965 FLUSHING 2 0.0000
966 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
967 ECZEMA 1 0.0000
968 ARTHROPATHY 1 0.0000
969 ASTHMA 2 0.0000
970 MYOCARDIAL INFARCTION 3 0.0000
971 BONE PAIN 1 0.0000
972 EMOTIONAL DISTRESS 2 0.0000
973 HYPERHIDROSIS 2 0.0000
974 DEVICE DIFFICULT TO USE 1 0.0000
975 BLOOD PRESSURE DECREASED 1 0.0000
976 DYSGEUSIA 1 0.0000
977 HALLUCINATION 1 0.0000
978 ACNE 1 0.0000
979 DIABETES MELLITUS 1 0.0000
980 HOSPITALISATION 2 0.0000
981 DRUG DOSE OMISSION BY DEVICE 1 0.0000
982 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
983 CARDIAC ARREST 1 0.0000
984 TOXICITY TO VARIOUS AGENTS 2 0.0000
985 MUSCLE SPASMS 2 0.0000
986 ADVERSE EVENT 1 0.0000
987 OVERDOSE 2 0.0000